HQ: Sydney, New South Wales, Australia
Cochlear
About Cochlear Company
Cochlear is a global expert in implantable hearing solutions.
Cochlear Specialization
Healthcare & Medical, Medical Devices
Cochlear General Information
HQ: Sydney, New South Wales, Australia
Business Type: Public
Employees: 1001-5000
Founded Date: 1982
Number of Exits: 1
Company Type: For Profit
Stock Symbol: ASX:COH
Operating Status: Active
Phone Number: +61294286555
Last Investment Activity: Jul 26, 2024
Investments Activity: Jul 26, 2024 Apr 19, 2024 Apr 19, 2024
Cochlear Email Format
{first_letter_first_name}{last_name}@cochlear.com — 100.0% (example: ssmith@domain.com)
Cochlear General Cochlear Emails
Legal Department
legal@cochlear.com
Contact details of 2 Cochlear other employees
Ming Lu
1 Emails
0 Phones
-
Work email
m*u@cochlear.com
Deeksha Kumar
1 Emails
0 Phones
-
Work email
d****r@cochlear.com
Similar Companies like Cochlear
HQ: Rahway, New Jersey, United States
Merck
Merck is a biopharmaceutical company that offers medicines a...
HQ: Rahway, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: 1891
Number of Exits: 9
Company Type: For Profit
Stock Symbol: NYSE:MRK
Operating Status: Active
HQ: New York, New York, United States
Pfizer
Pfizer is a biopharmaceutical company that provides affordab...
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 3, 2024
Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
HQ: New York, New York, United States
Pfizer
Pfizer is a biopharmaceutical company that provides affordab...
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 9, 2024
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.